ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000229512.1	Ponatinib	Bladder urothelial carcinoma	0.019838449	Sensitive
ENSG00000229512.1	Ponatinib	Pancreatic adenocarcinoma	0.031117496	Sensitive